Robert Matthew Lutz - 11 Nov 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Financial & Business Officer and Principal Accounting Officer
Signature
/s/Robert Matthew Lutz
Issuer symbol
IBIO
Transactions as of
11 Nov 2022
Net transactions value
$0
Form type
4
Filing time
15 Nov 2022, 07:33:42 UTC
Previous filing
31 Aug 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Award $0 +100,057 +4747% $0.000000 102,165 11 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 100,057 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 100,057 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 100,057 RSUs vest the earlier of: (i) July 1, 2023, or (ii) the successful achievement of the Corporation's 2023 objectives, as defined by the Board of Directors.

Remarks:

Chief Financial & Business Officer and Principal Accounting Officer